1-20 of 109
Sort by
News

A Trial of Nanoparticle Tracking of CAR-T Therapy Distribution in Patients with Extramedullary Myeloma Shows Promise

Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, A Trial of Nanoparticle Tracking of CAR-T Therapy Distribution in Patients with Extramedullary Myeloma Shows Promise
News

MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation

Leah Lawrence
Published: 2023
Abstract
Mid-July 2023
View News titled, MRD-Adapted Treatment Identified Newly Diagnosed Patients with MM for Intensification, Cessation
News

Order Matters: The Art and Science of Myeloma Drug Sequencing

Published: 2021
View News titled, Order Matters: The Art and Science of Myeloma Drug Sequencing
News

Is MRD Testing Worthwhile in Myeloma?

Published: 2021
View News titled, Is MRD Testing Worthwhile in Myeloma?
News

The Ins and Outs of Inclusion Criteria for Myeloma Clinical Trials

Published: 2021
View News titled, The Ins and Outs of Inclusion Criteria for Myeloma Clinical Trials
News

How I Treat in Brief: New Agents in Myeloma

Published: 2021
View News titled, How I Treat in Brief: New Agents in Myeloma
News

Previous Malignancy May Increase Risk of Subsequent Malignancy in Patients With Myeloma

Published: 2021
View News titled, Previous Malignancy May Increase Risk of Subsequent Malignancy in Patients With Myeloma
News

Early Phase Study of Selinexor With and Without Dexamethasone for Patients With Myeloma and Waldenström Macroglobulinemia

Published: 2021
View News titled, Early Phase Study of Selinexor With and Without Dexamethasone for Patients With Myeloma and Waldenström Macroglobulinemia
News

Doubling Down on Double Transplant for Myeloma: Updated Results from EMN02/H095

Published: 2021
View News titled, Doubling Down on Double Transplant for Myeloma: Updated Results from EMN02/H095
News

BCMA Antibody Drug Conjugate Active in Patients With Heavily Pretreated Myeloma

Published: 2021
View News titled, BCMA Antibody Drug Conjugate Active in Patients With Heavily Pretreated Myeloma
News

Controversies in Myeloma: The Who, When, and Why of Treatment

Published: 2021
View News titled, Controversies in Myeloma: The Who, When, and Why of Treatment
News

Multiple Myeloma Outcomes Differ Based on Socioeconomic Factors

Published: 2021
View News titled, Multiple Myeloma Outcomes Differ Based on Socioeconomic Factors
News

Denosumab Versus Zoledronic Acid for Reducing Time to Skeletal Events in Multiple Myeloma

Published: 2021
View News titled, Denosumab Versus Zoledronic Acid for Reducing Time to Skeletal Events in Multiple Myeloma
News

Adding Carfilzomib to Lenalidomide and Dexamethasone Extends Overall Survival in Multiple Myeloma

Published: 2021
View News titled, Adding Carfilzomib to Lenalidomide and Dexamethasone Extends Overall Survival in Multiple Myeloma
News

MRD Negativity Measured Via Next-Generation Sequencing Predicts Long-Term Survival in Myeloma

Published: 2021
View News titled, MRD Negativity Measured Via Next-Generation Sequencing Predicts Long-Term Survival in Myeloma
News

FDA Approves Once-Weekly Carfilzomib Combo for Relapsed or Refractory MM

Published: 2021
View News titled, FDA Approves Once-Weekly Carfilzomib Combo for Relapsed or Refractory MM
News

FDA Approves NGS-Based Test for Patients With ALL or MM

Published: 2021
View News titled, FDA Approves NGS-Based Test for Patients With ALL or MM
News

Carfilzomib Benefits Outweigh Potential for Cardiac Toxicity in Relapsed/Refractory Myeloma

Published: 2021
View News titled, Carfilzomib Benefits Outweigh Potential for Cardiac Toxicity in Relapsed/Refractory Myeloma
News

Can a Selinexor Combination STOMP Out Relapsed/Refractory Multiple Myeloma?

Published: 2021
View News titled, Can a Selinexor Combination STOMP Out Relapsed/Refractory Multiple Myeloma?
News

Selinexor Induces Deep Responses in Refractory Multiple Myeloma

Published: 2021
View News titled, Selinexor Induces Deep Responses in Refractory Multiple Myeloma